| Brief report: intestinal dysbiosis in ankylosing spondylitis ME Costello, F Ciccia, D Willner, N Warrington, PC Robinson, B Gardiner, ... Arthritis & rheumatology 67 (3), 686-691, 2015 | 443 | 2015 |
| Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis F Ciccia, G Guggino, A Rizzo, L Saieva, S Peralta, AR Giardina, ... Annals of the rheumatic diseases 74 (9), 1739-1747, 2015 | 298 | 2015 |
| Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with … G Triolo, A Ferrante, F Ciccia, A Accardo‐Palumbo, A Perino, A Castelli, ... Arthritis & Rheumatism 48 (3), 728-731, 2003 | 284 | 2003 |
| Overexpression of interleukin‐23, but not interleukin‐17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis F Ciccia, M Bombardieri, A Principato, AR Giardina, C Tripodo, R Porcasi, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 273 | 2009 |
| Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis F Ciccia, G Guggino, A Rizzo, R Alessandro, MM Luchetti, S Milling, ... Annals of the rheumatic diseases 76 (6), 1123-1132, 2017 | 271 | 2017 |
| Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study F Carubbi, P Cipriani, A Marrelli, PD Benedetto, P Ruscitti, O Berardicurti, ... Arthritis research & therapy 15, 1-15, 2013 | 210 | 2013 |
| Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the … F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ... Autoimmunity reviews 12 (2), 225-229, 2012 | 196 | 2012 |
| Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut … F Ciccia, A Accardo-Palumbo, A Rizzo, G Guggino, S Raimondo, ... Annals of the rheumatic diseases 73 (8), 1566-1574, 2014 | 188 | 2014 |
| Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. L Mancarella, F Bobbio-Pallavicini, F Ceccarelli, PC Falappone, ... The Journal of rheumatology 34 (8), 1670-1673, 2007 | 183 | 2007 |
| Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome F Ciccia, G Guggino, A Rizzo, A Ferrante, S Raimondo, AR Giardina, ... Annals of the rheumatic diseases 71 (2), 295-301, 2012 | 177 | 2012 |
| Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers P Ruscitti, P Cipriani, F Masedu, D Iacono, F Ciccia, V Liakouli, ... BMC medicine 14, 1-11, 2016 | 163 | 2016 |
| Safety of anti-tumor necrosis factor-α therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection C Ferri, G Ferraccioli, D Ferrari, M Galeazzi, G Lapadula, C Montecucco, ... The Journal of Rheumatology 35 (10), 1944-1949, 2008 | 152 | 2008 |
| Interleukin‐22 and interleukin‐22–producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis F Ciccia, A Accardo‐Palumbo, R Alessandro, A Rizzo, S Principe, ... Arthritis & Rheumatism 64 (6), 1869-1878, 2012 | 141 | 2012 |
| IL-34 is overexpressed in the inflamed salivary glands of patients with Sjögren’s syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16 … F Ciccia, R Alessandro, V Rodolico, G Guggino, S Raimondo, ... Rheumatology 52 (6), 1009-1017, 2013 | 134 | 2013 |
| International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis … R Giacomelli, A Afeltra, A Alunno, C Baldini, E Bartoloni-Bocci, ... Autoimmunity Reviews 16 (9), 911-924, 2017 | 133 | 2017 |
| Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding … P Ruscitti, P Cipriani, P Di Benedetto, V Liakouli, O Berardicurti, F Carubbi, ... Clinical & Experimental Immunology 182 (1), 35-44, 2015 | 130 | 2015 |
| Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors F Iannone, E Gremese, F Atzeni, D Biasi, C Botsios, P Cipriani, C Ferri, ... The Journal of rheumatology 39 (6), 1179-1184, 2012 | 130 | 2012 |
| Interstitial lung disease in systemic sclerosis: current and future treatment R Giacomelli, V Liakouli, O Berardicurti, P Ruscitti, P Di Benedetto, ... Rheumatology international 37, 853-863, 2017 | 120 | 2017 |
| Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry CP Denton, T Krieg, L Guillevin, B Schwierin, D Rosenberg, M Silkey, ... Annals of the rheumatic diseases 71 (5), 718-721, 2012 | 117 | 2012 |
| Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis F Ciccia, G Guggino, A Rizzo, A Manzo, B Vitolo, MP La Manna, ... Rheumatology 54 (12), 2264-2272, 2015 | 114 | 2015 |
Roberto GerliProfessore Ordinario di Reumatologia, Università PerugiaVerified email at unipg.it
